Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Caicun Zhou, Xingxiang Xu et al.|Journal of Thoracic Oncology|2021Cited by 311
Phosphorylated IRF3 promotes GSDME-mediated pyroptosis through RIPK1/FADD/caspase-8 complex formation during mitotic arrest in ovarian cancerWenjian Gong, Yong Fang|Cell Communication and Signaling|2025Cited by 7